NeuroSense Therapeutics NRSN
NASDAQ NRSN
$0.38 +0.03 (+7.39%)
At close: Aug 21, 2026 · 4:00 PM EDT

NeuroSense Therapeutics (NRSN) Property, Plant & Equipment (Net) (2020 - 2025)

NeuroSense Therapeutics (NRSN) Property, Plant & Equipment (Net) (2020 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 NeuroSense Therapeutics 9.68 Mn 9.47 Mn - 58,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 58,000.00
Dec 31, 2025 58,000.00
Jun 30, 2025 63,000.00
Jun 30, 2025 63,000.00
Dec 31, 2024 66,000.00
Dec 31, 2024 66,000.00
Sep 30, 2024 72,000.00
Sep 30, 2024 72,000.00
Jun 30, 2024 77,000.00
Jun 30, 2024 77,000.00
Mar 31, 2024 88,000.00
Mar 31, 2024 88,000.00
Dec 31, 2023 85,000.00
Dec 31, 2023 85,000.00
Sep 30, 2023 88,000.00
Sep 30, 2023 88,000.00
Jun 30, 2023 93.00 Mn
Jun 30, 2023 93.00 Mn
Mar 31, 2023 84,000.00
Mar 31, 2023 84,000.00